List of articles in "Drug" category - Page 370

Chlorphentermine (trade names Apsedon Desopimon Lucofen) is an appetite suppressant of the phenethylamine class. Developed in 1962 it is the 4-chloro derivative of the better known appetite suppressant phentermine which […]

Aprobarbital (as known in the United States or aprobarbitone (as known elsewhere) sold as Oramon Somnifaine and Allonal is a barbiturate derivative invented in the 1920s by Ernst Preiswerk. It […]

Allobarbital also known as allobarbitone and branded as Cibalgine or Dial-Ciba (in combination with ethyl carbamate) is a barbiturate derivative invented in 1912 by Ernst Preiswerk and Ernst Grether working […]

Visilizumab (tentative trade name Nuvion PDL BioPharma Inc.) is a humanized monoclonal antibody. It is being investigated for use as an immunosuppressive drug in patients with ulcerative colitis and Crohn’s […]

Toralizumab (IDEC 131) was a humanized monoclonal antibody and an immunosuppressive drug.

Tocilizumab (INN or atlizumab developed by Hoffmann–La Roche and Chugai and sold under the trade names Actemra and RoActemra) is an immunosuppressive drug mainly for the treatment of rheumatoid arthritis […]

Talizumab (TNX-901) is a humanized monoclonal antibody that was under development by Tanox in Houston Texas as a new-concept therapeutic for allergic diseases. The unique anti-IgE antibody was designed to […]

Siplizumab (MEDI-507) is a novel monoclonal antibody with a human IgG1 kappa directed to CD2. The agent has shown potent immunomodulatory effects selectively suppressing the function of T and NK […]

Ruplizumab (trade name Antova) is a humanized monoclonal antibody intended for the treatment of rheumatic diseases like systemic lupus erythematosus and lupus nephritis. A study showed that the drug was […]

Rovelizumab also known as LeukArrest and Hu23F2G is a humanized monoclonal antibody which was an experimental immunosuppressive drug. Rovelizumab was developed by Icos to treat patients suffering from haemorrhagic shock. […]